A critical appraisal of point-of-care coagulation testing in critically ill patients

Journal of Thrombosis and Haemostasis

Volumn 13, Issue 11, 2015, Pages 1960-1967

  Levi, M ^a   Hunt, B J ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Critical care; Hemorrhage; Platelet aggregation inhibitors; Point of care systems; Thoracic surgery; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10A INHIBITOR; CLOPIDOGREL; FRESH FROZEN PLASMA; HEPARIN; PROTHROMBIN ANTIBODY; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THIENOPYRIDINE DERIVATIVE; TRANEXAMIC ACID; ANTICOAGULANT AGENT;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ARTERY THROMBOSIS; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM DISEASE; COAGULOMETER; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CRITICALLY ILL PATIENT; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL CIRCULATION; FIBRINOLYSIS; HEART SURGERY; HEMOSTASIS; HEPARINIZATION; HUMAN; HYPERCOAGULABILITY; HYPOFIBRINOGENEMIA; INTENSIVE CARE; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MORBIDITY; MORTALITY; PARTIAL THROMBOPLASTIN TIME; PATIENT MONITORING; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; PLATELET AGGREGATION ASSAY; PLATELET REACTIVITY; POINT OF CARE TESTING; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; SHEAR STRESS; STENT THROMBOSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE DISORDER; THROMBOCYTE DYSFUNCTION; THROMBOCYTE FUNCTION; THROMBOCYTE FUNCTION ANALYZER; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOELASTOGRAPH; THROMBOELASTOGRAPHY; THROMBOSIS; BLOOD; BLOOD CLOTTING PARAMETERS; BLOOD COAGULATION DISORDERS; CHEMICALLY INDUCED; COMPLICATION; COST BENEFIT ANALYSIS; CRITICAL ILLNESS; DISEASE MANAGEMENT; DRUG MONITORING; ECONOMICS; HEMORRHAGE; OPERATIVE BLOOD LOSS; POINT OF CARE SYSTEM; POSTOPERATIVE HEMORRHAGE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); WOUNDS AND INJURIES;

ANTICOAGULANTS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; COST-BENEFIT ANALYSIS; CRITICAL CARE; CRITICAL ILLNESS; DISEASE MANAGEMENT; DRUG MONITORING; HEMORRHAGE; HUMANS; PLATELET FUNCTION TESTS; POINT-OF-CARE SYSTEMS; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THROMBELASTOGRAPHY; WOUNDS AND INJURIES;

EID: 84947026639     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.13126     Document Type: Review

References (48)

1. Levi M, Opal SM. Coagulation abnormalities in critically ill patients. Crit Care 2006; 10: 222.
2. Hunt BJ. Bleeding and coagulopathies in critical care. N Engl J Med 2014; 370: 847-59.
3. Vanderschueren S, De Weerdt A, Malbrain M, Vankersschaever D, Frans E, Wilmer A, Bobbaers H. Thrombocytopenia and prognosis in intensive care. Crit Care Med 2000; 28: 1871-6.
4. Levi M, Sivapalaratnam S. Hemostatic abnormalities in critically ill patients. Intern Emerg Med 2015; 10: 287-96.
5. Acosta JA, Yang JC, Winchell RJ, Simons RK, Fortlage DA, Hollingsworth-Fridlund P, Hoyt DB. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg 1998; 186: 528-33.
6. Ahmed A, Kojicic M, Herasevich V, Gajic O. Early identification of patients with or at risk of acute lung injury. Neth J Med 2009; 67: 268-71.
7. Schultz MJ. Early recognition of critically ill patients. Neth J Med 2009; 67: 266-7.
8. Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 2002; 30: 1765-71.
9. Bigeleisen PE, Kang Y. Thrombelastography as an aid to regional anesthesia: preliminary communication. Reg Anesth 1991; 16: 59-61.
10. Whitten CW, Greilich PE. Thromboelastography: past, present, and future. Anesthesiology 2000; 92: 1223-5.
11. Levi M. Self-management of anticoagulation. Expert Rev Cardiovasc Ther 2008; 6: 979-85.
12. Eller T, Busse J, Dittrich M, Flieder T, Alban S, Knabbe C, Birschmann I. Dabigatran, rivaroxaban, apixaban, argatroban and fondaparinux and their effects on coagulation POC and platelet function tests. Clin Chem Lab Med 2014; 52: 835-44.
13. Favaloro EJ. Clinical utility of the PFA-100. Semin Thromb Hemost 2008; 34: 709-33.
14. Faraoni D, Savan V, Levy JH, Theusinger OM. Goal-directed coagulation management in the perioperative period of cardiac surgery. J Cardiothorac Vasc Anesth 2013; 27: 1347-54.
15. Bolliger D, Tanaka KA. Roles of thrombelastography and thromboelastometry for patient blood management in cardiac surgery. Transfus Med Rev 2013; 27: 213-20.
16. Gorlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 2011; 115: 1179-91.
17. Wikkelsoe AJ, Afshari A, Wetterslev J, Brok J, Moeller AM. Monitoring patients at risk of massive transfusion with thrombelastography or thromboelastometry: a systematic review. Acta Anaesthesiol Scand 2011; 55: 1174-89.
18. Afshari A, Wikkelso A, Brok J, Moller AM, Wetterslev J. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev 2011: CD007871.
19. National Institute for Clinical Excellence (NICE). Detecting, managing and monitoring haemostasis: viscoelastometric point-of-care testing (ROTEM, TEG and Sonoclot systems). 2014. Diagnostics Guidance 13.
20. Cap A, Hunt BJ. The pathogenesis of traumatic coagulopathy. Anaesthesia 2015; 70(Suppl. 1): 96-101.
21. Johansson PI, Stensballe J, Ostrowski SR. Current management of massive hemorrhage in trauma. Scand J Trauma Resusc Emerg Med 2012; 20: 20-47.
22. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003; 54: 1127-30.
23. Johansson PI. Coagulation monitoring of the bleeding traumatized patient. Curr Opin Anaesthesiol 2012; 25: 235-41.
24. Theusinger OM, Levy JH. Point of care devices for assessing bleeding and coagulation in the trauma patient. Anesthesiol Clin 2013; 31: 55-65.
25. Cotton BA, Harvin JA, Kostousouv V, Minei KM, Radwan ZA, Schochl H, Wade CE, Holcomb JB, Matijevic N. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration. J Trauma Acute Care Surg 2012; 73: 365-70.
26. Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377: 1096-101.
27. Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C, Khan S, De'Ath HD, Allard S, Hart DP, Pasi KJ, Hunt BJ, Stanworth S, MacCallum PK, Brohi K. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013; 11: 307-14.
28. Solomon C, Rahe-Meyer N, Schochl H, Ranucci M, Gorlinger K. Effect of haematocrit on fibrin-based clot firmness in the FIBTEM test. Blood Transfus 2013; 11: 412-18.
29. Hill JS, Devenie G, Powell M. Point-of-care testing of coagulation and fibrinolytic status during postpartum haemorrhage: developing a thrombelastography(R)-guided transfusion algorithm. Anaesth Intensive Care 2012; 40: 1007-15.
30. Mallaiah S, Barclay P, Harrod I, Chevannes C, Bhalla A. Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia 2015; 70: 166-75.
31. Karlsson O, Jeppsson A, Hellgren M. Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? Int J Obstet Anesth 2014; 23: 10-17.
32. Karlsson O, Sporrong T, Hillarp A, Jeppsson A, Hellgren M. Prospective longitudinal study of thromboelastography and standard hemostatic laboratory tests in healthy women during normal pregnancy. Anesth Analg 2012; 115: 890-8.
33. Pavord S, Maybury H. How I treat postpartum hemorrhage. Blood 2015; 125: 2759-70.
34. Levi M. Diagnosis and treatment of disseminated intravascular coagulation. Int J Lab Hematol 2014; 36: 228-36.
35. Dempfle CE, Borggrefe M. Point of care coagulation tests in critically ill patients. Semin Thromb Hemost 2008; 34: 445-50.
36. Johansson PI, Stensballe J, Vindelov N, Perner A, Espersen K. Hypocoagulability, as evaluated by thrombelastography, at admission to the ICU is associated with increased 30-day mortality. Blood Coagul Fibrinolysis 2010; 21: 168-74.
37. Park MS, Martini WZ, Dubick MA, Salinas J, Butenas S, Kheirabadi BS, Pusateri AE, Vos JA, Guymon CH, Wolf SE, Mann KG, Holcomb JB. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma 2009; 67: 266-75.
38. Collins PW, Macchiavello LI, Lewis SJ, Macartney NJ, Saayman AG, Luddington R, Baglin T, Findlay GP. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. Br J Haematol 2006; 135: 220-7.
39. Muller MC, Meijers JC, Vroom MB, Juffermans NP. Utility of thromboelastography and/or thromboelastometry in adults with sepsis: a systematic review. Crit Care 2014; 18: R30.
40. Brenner T, Schmidt K, Delang M, Mehrabi A, Bruckner T, Lichtenstern C, Martin E, Weigand MA, Hofer S. Viscoelastic and aggregometric point-of-care testing in patients with septic shock - cross-links between inflammation and haemostasis. Acta Anaesthesiol Scand 2012; 56: 1277-90.
41. Daudel F, Kessler U, Folly H, Lienert JS, Takala J, Jakob SM. Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study. Crit Care 2009; 13: R42.
42. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86.
43. Pakala R, Waksman R. Currently available methods for platelet function analysis: advantages and disadvantages. Cardiovasc Revasc Med 2011; 12: 312-22.
44. Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Ruven HJ, Bal ET, Deneer VH, Harmsze AM, van der Heyden JA, Rensing BJ, Suttorp MJ, Hackeng CM, ten Berg JM. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. JAMA 2010; 303: 754-62.
45. Price MJ, Endemann S, Gollapudi RR, Valencia R, Stinis CT, Levisay JP, Ernst A, Sawhney NS, Schatz RA, Teirstein PS. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J 2008; 29: 992-1000.
46. Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, Buonamici P, Antoniucci D, Abbate R, Gensini GF. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up. Circulation 2009; 119: 237-42.
47. Stone GW, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri E, Gurbel PA, Xu K, Parise H, Kirtane AJ, Brodie BR, Mehran R, Stuckey TD. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study. Lancet 2013; 382: 614-23.
48. Range G, Yayehd K, Belle L, Thuaire C, Richard P, Cazaux P, Barbou F, Koning R, Chassaing S, Teiger E, Berthier R, Decomis MP, Claudel JP, Delarche N, Brunel P, De PF, Dupouy P, Beygui F, Albert F, Collet JP, et al. Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY). Arch Cardiovasc Dis 2014; 107: 225-35.